bimagrumab glp-1 The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition Phase 2 Study of Bimagrumab

Doctors report that GLP-1 medications, originally approved for obesity and diabetes, are increasingly being used to help women with Polycystic Ovary Syndrome (PCOS) a hormonal disorder often tied to weight gain, insulin resistance, and fertility issues

GLP-1 medications can help some people lose weightbut not everyone is a candidate

Formulated to: Support lean muscle growth and maintenance

#lifestylemedicine #doctorsinlinkedin #medicine #glp1 #weightloss #healthtech | 93 comments on LinkedIn

In recent years, many payers have taken steps to limit the costs of GLP-1s and introduced limits to coverage for the use of these products for weight loss.

100/box